• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核形态计量学仅在T1期前列腺腺癌中具有独立的预后价值。

Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas.

作者信息

Vesalainen S, Lipponen P, Talja M, Kasurinen J, Syrjänen K

机构信息

Department of Surgery, University of Kuopio, Finland.

出版信息

Prostate. 1995 Aug;27(2):110-7. doi: 10.1002/pros.2990270208.

DOI:10.1002/pros.2990270208
PMID:7638083
Abstract

A series of 325 patients with prostatic adenocarcinoma followed-up for over 13 years was subjected to histomorphometric analysis for the following prognostic factors: the Gleason score and 10 nuclear morphometric factors (mean nuclear area, nuclear perimeter, shortest and longest nuclear axis, form factor and their SDs), using the IBAS 1&2 image analyzer. Nuclear factors, Gleason score (P = 0.0013-0.0148), and T-category (P = 0.004-0.0107) were significantly interrelated, while the M-category was independent of the morphometric parameters. Nuclear factors (P = 0.0003-0.5), Gleason score (P < 0.0001), T-category (P < 0.0001) and M-category (P < 0.0001) predicted the disease outcome. In T1-2M0 tumors, the T-category (P = 0.0001), Gleason score (P < 0.0001), SD of nuclear area (P = 0.057), SD of nuclear perimetry (P = 0.039), mean shortest nuclear axis (P = 0.030), SD of the shortest nuclear axis (P = 0.0045), SD of the longest nuclear axis (P = 0.009), and nuclear form factor (P = 0.0123) were significant prognostic factors. In the multivariate survival analysis, the nuclear area had independent prognostic significance only in T1 tumors, whereas in other subcategories, the clinical stage, Gleason score, and patient age included all the available prognostic information. The results indicate that nuclear morphometric measurements are of borderline significance only in evaluating the intrinsic malignancy of prostatic adenocarcinoma.

摘要

对325例前列腺腺癌患者进行了长达13年以上的随访,并使用IBAS 1&2图像分析仪对以下预后因素进行组织形态计量分析:Gleason评分和10个核形态计量因素(平均核面积、核周长、最短和最长核轴、形态因子及其标准差)。核因素、Gleason评分(P = 0.0013 - 0.0148)和T分期(P = 0.004 - 0.0107)显著相关,而M分期与形态计量参数无关。核因素(P = 0.0003 - 0.5)、Gleason评分(P < 0.0001)、T分期(P < 0.0001)和M分期(P < 0.0001)可预测疾病预后。在T1 - 2M0肿瘤中,T分期(P = 0.0001)、Gleason评分(P < 0.0001)、核面积标准差(P = 0.057)、核周长标准差(P = 0.039)、平均最短核轴(P = 0.030)、最短核轴标准差(P = 0.0045)、最长核轴标准差(P = 0.009)和核形态因子(P = 0.0123)是显著的预后因素。在多变量生存分析中,核面积仅在T1肿瘤中具有独立的预后意义,而在其他亚组中,临床分期、Gleason评分和患者年龄包含了所有可用的预后信息。结果表明,核形态计量测量在评估前列腺腺癌的内在恶性程度方面仅具有临界意义。

相似文献

1
Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas.核形态计量学仅在T1期前列腺腺癌中具有独立的预后价值。
Prostate. 1995 Aug;27(2):110-7. doi: 10.1002/pros.2990270208.
2
Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2M0 prostatic adenocarcinoma.增殖细胞核抗原和p53表达作为T1-2M0前列腺腺癌预后因素的研究
Int J Cancer. 1994 Jul 15;58(2):303-8. doi: 10.1002/ijc.2910580226.
3
Biochemical parameters as prognostic factors in prostatic adenocarcinoma.生化参数作为前列腺腺癌的预后因素
Acta Oncol. 1995;34(1):53-9. doi: 10.3109/02841869509093639.
4
Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.前列腺腺癌的进展与生存:临床分期、Gleason分级、S期分数和DNA倍体的比较
Br J Cancer. 1994 Aug;70(2):309-14. doi: 10.1038/bjc.1994.298.
5
Mitotic activity and prognosis in prostatic adenocarcinoma.前列腺腺癌的有丝分裂活性与预后
Prostate. 1995 Feb;26(2):80-6. doi: 10.1002/pros.2990260204.
6
The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
Int J Cancer. 1993 Oct 21;55(4):547-54. doi: 10.1002/ijc.2910550405.
7
A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumour.
Anticancer Res. 1996 Jul-Aug;16(4A):2095-100.
8
[Prognostic value of DNA ploidy and nuclear morphometry in metastatic prostate cancer].[DNA倍体和核形态计量学在转移性前列腺癌中的预后价值]
Actas Urol Esp. 2004 Apr;28(4):298-307. doi: 10.1016/s0210-4806(04)73078-8.
9
Prognostic value of nuclear morphometry on needle biopsy from patients with prostate cancer: is volume-weighted mean nuclear volume superior to other morphometric parameters?前列腺癌患者穿刺活检组织细胞核形态测量的预后价值:体积加权平均核体积是否优于其他形态测量参数?
Urology. 2000 Mar;55(3):377-81. doi: 10.1016/s0090-4295(99)00456-2.
10
Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma.肿瘤血管生成及基底膜结构作为T1-2MO期前列腺腺癌的预后因素
Anticancer Res. 1994 Mar-Apr;14(2B):709-14.

引用本文的文献

1
An evaluation of irreversible electroporation thresholds in human prostate cancer and potential correlations to physiological measurements.人类前列腺癌中不可逆电穿孔阈值的评估及其与生理测量的潜在相关性。
APL Bioeng. 2017 Oct 9;1(1):016101. doi: 10.1063/1.5005828. eCollection 2017 Dec.
2
Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.通过核大小对前列腺癌循环肿瘤细胞进行亚分类揭示了内脏转移患者中存在非常小的核循环肿瘤细胞。
Cancer. 2015 Sep 15;121(18):3240-51. doi: 10.1002/cncr.29455. Epub 2015 May 14.
3
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.
一项评估 1α-羟基维生素 D2 调节临床局限性前列腺癌和高级别 PIN 患者中间终点生物标志物的 II 期开放性标签、多中心临床试验
Prostate. 2013 Jun;73(9):970-8. doi: 10.1002/pros.22644. Epub 2013 Jan 17.
4
Prostate cancer: serum and tissue markers.前列腺癌:血清及组织标志物
Rev Urol. 2001;3 Suppl 2(Suppl 2):S11-9.
5
Prognostic factors in prostate cancer.前列腺癌的预后因素。
Diagn Pathol. 2006 Apr 3;1:4. doi: 10.1186/1746-1596-1-4.